TRAVERSA SERGIO 4
4 · RELMADA THERAPEUTICS, INC. · Filed Aug 28, 2025
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-08-26$0.62/sh+80,545$49,938→ 814,569 total - Purchase
Common Stock
2025-08-27$0.67/sh+129,455$86,735→ 944,024 total - Purchase
Common Stock
2025-08-28$0.74/sh+55,976$41,422→ 1,000,000 total
Footnotes (4)
- [F1]The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- [F2]Purchase prices range from $0.61 to $0.65 per share, inclusive.
- [F3]Purchase prices range from $0.65 to $0.69 per share, inclusive.
- [F4]Purchase prices range from $0.68 to $0.79 per share, inclusive.